The selenoprotein thioredoxin reductase is expressed in peripheral blood monocytes and THP1 human myeloid leukemia cells regulation by 1,25- dihydroxyvitamin D3 and selenite

BioFactors

Volumn 10, Issue 4, 1999, Pages 329-338

  Schütze, Norbert ^a   Fritsche, Jana ^b   Ebert Dümig, Regina ^a   Schneider, Doris ^a   Köhrle, Josef ^a   Andreesen, Reinhard ^b   Kreutz, Marina ^b   Jakob, Franz ^a,c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c Klinische Forschergruppe   (Germany)

Author keywords

Monocyte; Thioredoxin reductase; Vitamin D3

Indexed keywords

CALCITRIOL; SELENITE; SELENOPROTEIN; THIOREDOXIN REDUCTASE;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG EFFECT; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; LEUKEMIA CELL; MACROPHAGE ACTIVATION; MONOCYTE; MYELOID LEUKEMIA; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; TISSUE SPECIFICITY;

EID: 2042546894     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520100403     Document Type: Article

References (55)

1. J.S. Adams and S.Y. Ren, Autoregulation of 1,25-dihydroxyvitamin D synthesis in macrophage mitochondria by nitric oxide, Endocrinology 137 (1996), 4514-4517.
2. M. Andersson, A. Holmgren and G. Spyrou, NK-lysin, a disulfide-containing effector peptide of T-lymphocytes, is reduced and inactivated by human thioredoxin reductase. Implication for a protective mechanism against NK-lysin cytotoxicity, J. Biol. Chem. 271 (1996), 10 116-10 120.
3. K. Becker, S. Müller, M.A. Keese, R.D. Walter and R.H. Schirmer, A glutathione reductase-like flavoenzyme of the malaria parasite Plasmodium falciparum: Structural considerations based on the DNA sequence, Biochem. Soc. Trans. 24 (1996), 67-72.
4. D. Behne, C. Weiss-Nowak, M. Kalcklösch, C. Westphal, H. Gessner and A. Kyriakopoulos, Studies on the distribution and characteristics of new mammalian selenium-containing proteins, Analyst 120 (1995), 823-825.
5. N.H. Bell, Renal and nonrenal 25-hydroxyvitamin D-1α-hydroxylases and their clinical significance, J. Bone Min. Res. 13 (1998), 350-353.
6. M.J. Berry and P.R. Larsen, Recognition of UGA as a selenocysteine codon in eucaryotes: a review of recent progress, Biochem. Soc. Trans. 21 (1993), 872-832.
7. D. Bikle, Vitamin D: New actions, new analogs, new therapeutic potential, Endocrine Rev. 13 (1992), 765-784.
8. M.G. Bischof, K. Redlich, C. Schiller, M.V. Chirayath, M. Uskokovic, M. Peterlik and H.S. Cross, Growth inhibitory effects on human colon adenocarcinoma-derived Caco-2 cells and calcemic potential of 1 alpha,25-dihydroxyvitamin D3 analogs: structure-function relationships, J. Pharmacol. Exp. Ther. 275 (1995), 1254-1260.
9. R. Bouillon, W.H. Okamura and A.W. Norman, Structure-function relationships in the vitamin D endocrine system, Endocrine Rev. 16 (1995), 200-257.
10. M.M. Bradford, A rapid and sensitive method for the quantification of microgram quantities of protein utilising the principle of protein-dye binding, Anal. Biochem. 7 (1976), 248-254.
11. C.M. Bunce, G. Brown and M. Hewison, Vitamin D and hematopoiesis, Trends Endocrinol. Metabol. 8 (1997), 245-251.
12. D. Casso and D. Beach, A mutation in a thioredoxin reductase homolog suppresses p53-induced growth inhibition in the fission yeast Schizosaccharomyces pombe, Mol. Gen. Genet. 252 (1996), 518-529.
13. J.M. Chirgwin, A.E. Przybyla, R.J. MacDonald and W.J. Rutter, Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease, Biochemistry 18 (1979), 5294-5299.
14. P. Chomczynski and N. Sacchi, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal. Biochem. 162 (1987), 156-159.
15. I. Dreher, T. Jakobs and J. Köhrle, Cloning and characterization of the human selenoprotein P promoter. Response of selenoprotein P expression to cytokines in the liver, J. Biol. Chem. 272 (1997), 29 364-29 371.
16. H. Follmann and I. Häberlein, Thioredoxins: universal, yet specific thiol-disulfide redox cofactors, Biofactors 5 (1996), 147-156.
17. 3-inducible transcript (DDVit 1) in human blood monocytes, Biochem. Biophys. Res. Comm. 235 (1997), 407-412.
18. J.R. Gasdaska, P.Y. Gasdaska, A. Gallegos and G. Powis, Human thioredoxin reductase gene localization to chromosomal position 12q23-q24.1 and mRNA distribution in human tissue, Genomics 37 (1996), 257-259.
19. J.R. Gasdaska, D.L. Kirkpatrick, W. Montfort, M. Kuperus, S.R. Hill, M. Berggren and G. Powis, Oxidative inactivation of thioredoxin as a cellular growth factor and protection by a Cys73→Ser mutation, Biochem. Pharmacol. 52 (1996), 1741-1747.
20. P.Y. Gasdaska, J.R. Gasdaska, S. Cochran and G. Powis, Cloning and sequencing of a human thioredoxin reductase, FEBS Lett. 373 (1995), 5-9.
21. V.N. Gladyshev, K.T. Jeang and T.C. Stadtman, Selenocysteine, identified as the penultimate C-terminal residue in human T-cell thioredoxin reductase, corresponds to TGA in the human placental gene, Proc. Natl. Acad. Sci. USA 93 (1996), 6146-6151.
22. M.R. Haussler, G.K. Whitfield, C.A. Haussler, J.C. Hsieh, P.D. Thompson, S.H. Selznick, C.E. Dominguez and P.W. Jurutka, The nuclear vitamin D receptor: Biological and molecular regulatory properties revealed, J. Bone Min. Res. 13 (1998), 325-349.
23. T.E. Hedlund, K.A. Moffatt and G.J. Miller, Stable expression of the nuclear vitamin D receptor in the human prostatic carcinoma cell line JCA-1: evidence that the antiproliferative effects of 1 alpha, 25-dihydroxyvitamin D3 are mediated exclusively through the genomic signaling pathway, Endocrinology 137 (1996), 1554-1561.
24. M. Hewison, M. Dabrowski, L. Faulkner, E. Hughson, S. Vadher, A. Rut, P.M. Brickell, J.L. O'Riordan and D.R. Katz, Transfection of vitamin D receptor cDNA into the monoblastoid cell line U937. The role of vitamin D3 in homotypic macrophage adhesion, J. Immunol. 153 (1994), 5709-5719.
25. M. Hewison, M. Dabrowski, S. Vadher, L. Faulkner, F.J. Cockerill, P.M. Brickell, J.L. O'Riordan and D.R. Katz, Antisense inhibition of vitamin D receptor expression induces apoptosis in monoblastoid U937 cells, J. Immunol. 156 (1996), 4391-4400.
26. K.E. Hill, G.W. McCollum, M.E. Boeglin and R.F. Burk, Thioredoxin reductase is decreased by selenium deficiency, Biochem. Biophys. Res. Comm. 234 (1997), 293-295.
27. K. Hirota, M. Matsui, S. Iwata, A. Nishiyama, K. Mori and J. Yodoi, AP-1 transcriptional activity is regulated by a direct association between thioredoxin and ref-1, Proc. Natl. Acad. Sci. USA, 94 (1997), 3633-3638.
28. A. Holmgren and M. Björnstedt, Thioredoxin and thioredoxin reductase, Methods Enzymol. 252 (1996), 199-208.
29. K. Hori, D. Hatfield, F. Maldarelli, B.J. Lee and K.A. Clouse, Selenium supplementation suppresses tumor necrosis factor alpha-induced human immunodeficiency virus type 1 replication in vitro, AIDS Res. Hum. Retroviruses 13 (1997), 1325-1332.
30. F. Jakob, F. Gieseler, A. Tresch, S. Hammer, J. Seufert and D. Schneider, Kinetics of nuclear translocation and turnover of the vitamin D receptor in human HL 60 leukemia cells and peripheral blood lymphocytes - coincident rise of DNA-relaxing activity in nuclear extracts, J. Ster. Biochem. Molec. Biol. 42 (1992), 11-16.
31. F. Jakob, J. Seufert, C. Sarrazin, D. Schneider, J. Köhrle and H.-P. Tony, Topoisomerase I-inhibition enhances vitamin D-responsive expression of the receptor for lipopolysaccharide binding protein CD 14, Biochem. Biophys. Res. Comm. 199 (1994), 531-539.
32. S. Kamimura, M. Gallieni, M. Zhong, W. Beron, E. Slatopolsky and A. Dusso, Microtubules mediate cellular 25-hydroxyvitamin D3 trafficking and the genomic response to 1,25-dihydroxyvitamin D3 in normal human monocytes, J. Biol. Chem. 270 (1995), 22 160-22 166.
33. K.F. Kane, M.J. Langman and G.R. Williams, Antiproliferative responses of two human colon cancer cell lines to vitamin D3 are differently modified by 9-cis-retinoic acid, Cancer Res. 56 (1996), 623-632.
34. J. Köhrle, I. Dreher and F. Jakob, Selenoproteins and antioxidative defense systems, in: Proceedings of the Siebold Memorial International Medical Symposium, Nagasaki, Japan, 26-29 September 1996, in press.
35. J. Köhrle, Thyroid hormone deiodinases - a selenoenzyme family acting as gate keepers to thyroid hormone action, Acta Med. Austriaca 1 (1996), 17-30.
36. L. Leist, B. Raab, S. Maurer, U. Rösick and R. Brigelius-Flohé, Conventional cell culture media does not adequately supply cells with antioxidants and thus facilitate peroxide-induced genotoxicity, Free Radicals Biol. Med. 21 (1996), 297-306.
37. M. Matsui, M. Oshima, H. Oshima, K. Takaku, T. Maruyama, J. Yodoi and M.M. Taketo, Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene, Dev. Biol. 178 (1996), 179-185.
38. B.L. Mau and G. Powis, Inhibition of cellular thioredoxin reductase by diaziquone and doxorubicin. Relationship to the inhibition of cell proliferation and decreased ribonucleotide reductase activity, Biochem. Pharmacol. 43 (1992), 1621-1627.
39. K. Mitomo, K. Nakayama, K. Fujimoto, X. Sun, S. Seki and K. Yamamoto, Two different cellular redox systems regulate the DNA-binding activity of the p50 subunit of NF-κB in vitro, Gene 145 (1994), 197-203.
40. H. Nakshatri, P. Bhat-Nakshatri and R.A. Currie, Subunit association and DNA binding activity of the heterotrimeric transcription factor NF-Y is regulated by cellular redox, J. Biol. Chem. 271 (1996), 28 784-28 791.
41. A.W. Norman, The vitamin D endocrine system: manipulation of structure-function relationships to provide opportunities for development of new cancer chemopreventive and immunosuppressive agents, J. Cell Biochem. Suppl. 22 (1995), 218-225.
42. H.A.P. Pols, J.C. Birkenhäger and J.P.T.M. van Leeuwen, Vitamin D analogues: from molecule to clinical application, Clin. Endocrinol. 40 (1994), 285-292.
43. G. Powis, J.E. Oblong, P.Y. Gasdaska, M. Berggren, S.R. Hill and D.L. Kirkpatrick, The thioredoxin/thioredoxin reductase redox system and control of cell growth, Oncol. Res. 6 (1996), 539-544.
44. W.A. Prinz, F. Aslund, A. Holmgren and J. Beckwith, The role of the thioredoxin and glutaredoxin pathways in reducing protein disulfide bonds in the Escherichia coli cytoplasm, J. Biol. Chem. 272 (1997), 15 661-15 667.
45. M. Rehli, S.W. Krause, M. Kreutz and R. Andreesen, Carboxypeptidase M is identical to the MAX.1 antigen and its expression is associated with monocyte to macrophage differentiation, J. Biol. Chem. 270(26) (1995), 15 644-15 649.
46. A. Rosen, P. Lundman, M. Carlsson, K. Bhavani, B.R. Srinivasa, G. Kjellstrom and K. Nilsson, A CD4+ T cell line-secreted factor, growth promoting for normal and leukemic B cells, identified as thioredoxin, Int. Immunol. 7(4) (1995), 625-633.
47. 2-vitamin D3-responsive gene in human osteoblasts - regulation by selenite, Biofactors 7 (1998), 299-310.
48. G. Spyrou, M. Bjornstedt, S. Kumar and A. Holmgren, AP-1 DNA-binding activity is inhibited by selenite and selenodiglutathione, FEBS Lett. 368 (1995), 59-63.
49. T.C. Stadtman, Selenocysteine, Ann. Rev. Biochem. 65 (1996), 83-100.
50. T. Tamura and T.C. Stadtman, A new selenoprotein from human lung adenocarcinoma cells. Purification, properties, and thioredoxin reductase activity, Proc. Natl. Acad. Sci. USA 93 (1996), 1006-1011.
51. F. Ursini, M. Maiorino, R. Brigelius-Flohé, K.D. Aumann, A. Roveri, D. Schomburg and L. Flohé, Diversity of glutathione peroxidases, Methods Enzymol. 252 (1995), 38-53.
52. M.R. Walters, Newly identified actions of the vitamin D endocrine system, Endocrine Rev. 13 (1992), 719-764.
53. G.K. Whitfield, J.C. Hsieh, P.W. Jurutka, S.H. Selznick, C.A. Haussler, P.N. MacDonald and M.R. Haussler, Genomic actions of 1,25-dihydroxyvitamin D3, J. Nutr. 125 (1995), 1690S-1694S.
54. B. Wieles, T.H. Ottenhoff, T.M. Steenwijk, K.L. Franken, R.R. de Vries and J.A. Langermans, Increased intracellular survival of Mycobacterium smegmatis containing the Mycobacterium leprae thioredoxin-thioredoxin reductase gene, Infect. Immun. 65 (1997), 2537-2541.
55. X. Wu, N.H. Bishopric, D.J. Discher, B.J. Murphy and K.A. Webster, Physical and functional sensitivity of zinc finger transcription factors to redox change, Mol. Cell. Biol. 16 (1996), 1035-1046.